$SOTK

COCCIO CHRISTOPHER L sold $91K of SOTK

COCCIO CHRISTOPHER L sold 17,000 shares of SONO TEK CORP (SOTK) at $5.38 on 2026-07-21.

Original reporting
SEC EDGAR · COCCIO CHRISTOPHER L
Published Jul 23, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SOTK
Neutral
medium confidence
Mentioned
$SOTK
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SOTKNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale details (17,000 shares at $5.3750) and post-transaction holdings (292,447 shares).

02

Market read

Traders may monitor SOTK for any clustering of insider sales or unusual trading activity, but the filing alone does not change fundamentals.

03

What to watch

The filing does not state motivations, and the absence of a 10b5-1 plan does not prove negative expectations; it only removes one common explanation.

Relevance 3/10Novelty 3/10Timing: Filed after-hours on 2026-07-23, reflecting a sale dated 2026-07-21.

Background

This is an SEC Form 4 insider transaction disclosure for Sono Tek Corp (SOTK).

Company-level read

Ticker impact

$SOTKNeutralMedium confidence
Context

Sono Tek Corp disclosed an insider open-market sale by director COCCIO CHRISTOPHER L of 17,000 shares at $5.3750 on 2026-07-21.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-on insider activity or unusual volume.

Evidence & confidence

Form 4 provides transaction details but does not include earnings, guidance, or operational changes. The sale size is moderate and the article lacks any linkage to company performance or new corporate events.

Market effects

No sector-level read-across; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales are often planned for diversification or liquidity needs; without additional context, the signal may be noise.

Key entities

  • SONO TEK CORP

    Company that filed the Form 4 insider transaction disclosure.

  • COCCIO CHRISTOPHER L

    Director who sold 17,000 shares in an open-market sale.

Related articles

$SOTKMedAI 8/10

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.

$SOTKMed

SONO TEK CORP (SOTK): Results of Operations and Financial Condition

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati

$SOTKMedAI 9/10

Sono-Tek Corporation Q4 2026 Earnings Call Summary

Sono-Tek Corporation reported Q4 2026 results driven by a shift to higher-ASP, turnkey production systems. The company said medical demand rose 54% year over year, while clean energy orders fell 19% amid government policy changes. Gross margin increased to 51% and operating income rose 81%. Management projected growth and profitability in fiscal 2027 H1, with flat-to-modestly higher full-year revenue amid clean-energy uncertainty. Cash was $14.8 million with no debt.

$SOTKMedAI 9/10

Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Sono-Tek (Nasdaq: SOTK) reported FY2026 net sales of $20.9M (+2% YoY), gross margin of 51% (up from 47.5%), operating income of $1.82M (+81%), and net income of about $1.8M (+42%), according to the company. Q4 net sales were $5.6M (+10%). Backlog was $9.1M. The company expects continued 1H FY2027 revenue growth driven by medical and high-ASP systems; FY2027 revenue projected flat to modestly higher.